Quick Answer
ORTHOPEDIATRICS CORP reported Cash and Equivalents of $19.56 million for fiscal year 2025.
ORTHOPEDIATRICS CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $19.56M | -55.4% |
| 2024 | $43.82M | +41.1% |
| 2023 | $31.05M | +245.4% |
| 2022 | $8.99M | +17.7% |
| 2021 | $7.64M | -73.4% |
| 2020 | $28.76M | -59.4% |
| 2019 | $70.78M | +16.6% |
| 2018 | $60.69M | +42.5% |
| 2017 | $42.58M | +2546.5% |
| 2016 | $1.61M | -58.5% |
| 2015 | $3.88M | -41.1% |
| 2014 | $6.58M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.83M | -67.0% | -62.2% |
| June 30, 2025 | $44.55M | +54.0% | +33.2% |
| March 31, 2025 | $33.44M | +54.8% | -23.7% |
| December 31, 2024 | $43.82M | +41.1% | -14.2% |
| September 30, 2024 | $51.05M | +379.8% | +76.5% |
| June 30, 2024 | $28.93M | +197.8% | +33.9% |
| March 31, 2024 | $21.60M | -37.7% | -30.4% |
| December 31, 2023 | $31.05M | +245.4% | +191.9% |
- ORTHOPEDIATRICS CORP showed a decrease of -55.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2014–2025 period, ORTHOPEDIATRICS CORP’s cash and equivalents has grown by 197.2% (from $6.58 million to $19.56 million).
- The most recent figure is from ORTHOPEDIATRICS CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: